Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome

被引:85
作者
Mafaldo Soares, Elvira Maria
Azevedo, George Dantas [1 ]
Nobrega Gadelha, Rafael Goncalves
Araujo Moura Lemos, Telma Maria [2 ]
Oliveira Maranhao, Tecia Maria
机构
[1] Ctr Biociencias, Dept Morfol, BR-59078970 Natal, RN, Brazil
[2] Univ Fed Rio Grande do Norte, Programa Posgrad Ciencias Saude, Ctr Ciencias Saude, Dept Anal Clin, BR-59072970 Natal, RN, Brazil
关键词
metabolic syndrome; polycystic ovary syndrome; cardiovascular;
D O I
10.1016/j.fertnstert.2007.03.081
中图分类号
R71 [妇产科学];
学科分类号
100211 [妇产科学];
摘要
Objective: To determine the prevalence of the metabolic syndrome (MetS) and its components in Brazilian women with polycystic ovary syndrome (PCOS). Design: Cross-sectional study. Setting: University Hospital, Federal University of Rio Grande do Norte, Natal-RN, Brazil. Patient(s): 102 women with PCOS by the Rotterdam consensus criteria. Intervention(s): None. Main Outcome Measure(s): Clinical and biochemical parameters for MetS as defined by the National Cholesterol Education Program Adult Treatment Panel (NCEP ATP III). Result(s): The prevalence for individual components of MetS were high-density lipoprotein cholesterol level < 50 mg/dL in 69.6%, waist circumference >= 88 cm in 57.9%, triglyceride level >= 150 mg/dL in 31.7%, blood pressure >= 130/85 mm Hg in 18.6%, and fasting glucose concentrations >= 110 mg/dL in 2.9%. Three or more of these individual criteria were present in 29 (28.4%) of the patients. The prevalence of MetS increased with body mass index: 3.2%, 19.2% and 52.3% for normal, overweight, and obese women, respectively. Conclusion(s): These findings indicate that Brazilian women with PCOS have a high prevalence of MetS and its individual components, particularly a decreased high-density lipoprotein cholesterol level. Thus, these women are at increased risk of diabetes mellitus and cardiovascular disease.
引用
收藏
页码:649 / 655
页数:7
相关论文
共 38 条
[1]
[Anonymous], 1997, WHO TECHN REP SER
[2]
Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome [J].
Apridonidze, T ;
Essah, PA ;
Iuorno, MJ ;
Nestler, JE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (04) :1929-1935
[3]
Araújo Leila Maria Batista, 2005, Arq Bras Endocrinol Metab, V49, P557, DOI 10.1590/S0004-27302005000400014
[4]
Obesity and polycystic ovary syndrome [J].
Barber, T. M. ;
McCarthy, M. I. ;
Wass, J. A. H. ;
Franks, S. .
CLINICAL ENDOCRINOLOGY, 2006, 65 (02) :137-145
[5]
HYPERANDROGENISM, INSULIN RESISTANCE, AND ACANTHOSIS NIGRICANS SYNDROME - A COMMON ENDOCRINOPATHY WITH DISTINCT PATHOPHYSIOLOGIC FEATURES [J].
BARBIERI, RL ;
RYAN, KJ .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1983, 147 (01) :90-101
[6]
Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS [J].
Carmina, E ;
Napoli, N ;
Longo, RA ;
Rini, GB ;
Lobo, RA .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2006, 154 (01) :141-145
[7]
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome [J].
Chang, J ;
Azziz, R ;
Legro, R ;
Dewailly, D ;
Franks, S ;
Tarlatzis, BC ;
Fauser, B ;
Balen, A ;
Bouchard, P ;
Dahlgren, E ;
Devoto, L ;
Diamanti, E ;
Dunaif, A ;
Filicori, M ;
Homburg, R ;
Ibanez, L ;
Laven, J ;
Magoffin, D ;
Nestler, J ;
Norman, RJ ;
Pasquali, R ;
Pugeat, M ;
Strauss, J ;
Tan, S ;
Taylor, A ;
Wild, R ;
Wild, S ;
Ehrmann, D ;
Lobo, R .
FERTILITY AND STERILITY, 2004, 81 (01) :19-25
[8]
Differences in the prevalence of metabolic syndrome according to the ATP-III and WHO definitions [J].
Cosmea, AA ;
Fernández, VL ;
García, SS ;
García, TA ;
Díaz, MAP ;
González, LD .
MEDICINA CLINICA, 2005, 124 (10) :368-370
[9]
de Oliveira Ernesto P, 2006, Arq Bras Endocrinol Metabol, V50, P456, DOI 10.1590/S0004-27302006000300008
[10]
INSULIN RESISTANCE - A MULTIFACETED SYNDROME RESPONSIBLE FOR NIDDM, OBESITY, HYPERTENSION, DYSLIPIDEMIA, AND ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE [J].
DEFRONZO, RA ;
FERRANNINI, E .
DIABETES CARE, 1991, 14 (03) :173-194